ImmunOs Therapeutics
Dr. Darryl H. Patrick is a pharmaceutical research and development executive specializing in non-clinical development for over 30 years. He was Vice President, Exploratory Development at Vertex Pharmaceuticals and responsible for all non-clinical development activities and clinical pharmacology directing programs through to proof-of-concept. While at Vertex, he was a member of the management team and responsible for the first NCE developed within the Company. Darryl began his career at Merck/MSD Research Laboratories, working in numerous roles over 20 years and ultimately serving as Vice President/Head, Worldwide Safety Assessment. In this function, he was responsible for all non-clinical aspects of potential drug development candidates, including toxicologic evaluation, definition of pre-clinical drug development candidate plans, interaction with drug development teams, and preparation of regulatory submissions including INDs/NDAs.
This person is not in any offices